Laura M. Kettyle

642 total citations
17 papers, 433 citations indexed

About

Laura M. Kettyle is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Laura M. Kettyle has authored 17 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Hematology and 4 papers in Immunology. Recurrent topics in Laura M. Kettyle's work include Acute Myeloid Leukemia Research (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Protein Degradation and Inhibitors (5 papers). Laura M. Kettyle is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Protein Degradation and Inhibitors (5 papers). Laura M. Kettyle collaborates with scholars based in United Kingdom, Canada and United States. Laura M. Kettyle's co-authors include Alexander Thompson, Joana Carrelha, Ruggiero Norfo, Claus Nerlov, Verónica Alcolea, Kari Högstrand, Adriana Rosa Gambardella, Alejandra Sanjuán-Pla, Tiago C. Luís and Sten Eirik W. Jacobsen and has published in prestigious journals such as Nature, Blood and Genome biology.

In The Last Decade

Laura M. Kettyle

17 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura M. Kettyle United Kingdom 9 277 240 146 44 41 17 433
Swathi-Rao Narayanagari United States 4 194 0.7× 200 0.8× 90 0.6× 61 1.4× 45 1.1× 4 374
Kathleen Hueneman United States 9 207 0.7× 207 0.9× 145 1.0× 62 1.4× 62 1.5× 24 392
Bilyana Stoilova United Kingdom 7 177 0.6× 179 0.7× 90 0.6× 44 1.0× 29 0.7× 10 287
Milica Vukovic United Kingdom 8 249 0.9× 174 0.7× 61 0.4× 37 0.8× 130 3.2× 10 433
Zohar Sachs United States 12 246 0.9× 138 0.6× 73 0.5× 53 1.2× 82 2.0× 36 383
Maria Rosaria Imperato United Kingdom 9 282 1.0× 242 1.0× 72 0.5× 24 0.5× 61 1.5× 12 402
Arnaud Villacreces France 11 145 0.5× 172 0.7× 194 1.3× 63 1.4× 60 1.5× 18 415
Sherif Ibrahim United States 6 328 1.2× 132 0.6× 54 0.4× 42 1.0× 88 2.1× 6 459
Agnieszka A. Wendorff United States 6 446 1.6× 179 0.7× 100 0.7× 38 0.9× 114 2.8× 8 642
Cindy Cavelier France 6 238 0.9× 256 1.1× 90 0.6× 45 1.0× 72 1.8× 6 418

Countries citing papers authored by Laura M. Kettyle

Since Specialization
Citations

This map shows the geographic impact of Laura M. Kettyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura M. Kettyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura M. Kettyle more than expected).

Fields of papers citing papers by Laura M. Kettyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura M. Kettyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura M. Kettyle. The network helps show where Laura M. Kettyle may publish in the future.

Co-authorship network of co-authors of Laura M. Kettyle

This figure shows the co-authorship network connecting the top 25 collaborators of Laura M. Kettyle. A scholar is included among the top collaborators of Laura M. Kettyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura M. Kettyle. Laura M. Kettyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wojtowicz, Edyta E., Jayna J. Mistry, Charlotte Hellmich, et al.. (2023). Panhematopoietic RNA barcoding enables kinetic measurements of nucleate and anucleate lineages and the activation of myeloid clones following acute platelet depletion. Genome biology. 24(1). 152–152. 3 indexed citations
2.
Hill, Claire, Seamus Duffy, Laura M. Kettyle, et al.. (2023). Differential Methylation of Telomere-Related Genes Is Associated with Kidney Disease in Individuals with Type 1 Diabetes. Genes. 14(5). 1029–1029. 8 indexed citations
3.
Conole, Daniel, Laura M. Kettyle, Alison O’Mahony, et al.. (2022). A tubulin binding molecule drives differentiation of acute myeloid leukemia cells. iScience. 25(8). 104787–104787. 4 indexed citations
4.
Genua, Cristina Di, Ruggiero Norfo, Alba Rodríguez-Meira, et al.. (2019). Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutation. Haematologica. 104(11). 2215–2224. 11 indexed citations
5.
Kettyle, Laura M., Ivan Grishagin, Glenda J. Dickson, et al.. (2019). Pathways, Processes, and Candidate Drugs Associated with a Hoxa Cluster-Dependency Model of Leukemia. Cancers. 11(12). 2036–2036. 3 indexed citations
6.
Carrelha, Joana, Yiran Meng, Laura M. Kettyle, et al.. (2018). Hierarchically Related Lineage-Restricted Fates of Multipotent Hematopoietic Stem Cells. Experimental Hematology. 64. S57–S58. 1 indexed citations
7.
Carrelha, Joana, Yiran Meng, Laura M. Kettyle, et al.. (2018). Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells. Nature. 554(7690). 106–111. 252 indexed citations
8.
Matchett, Kyle B., Ivan Grishagin, Laura M. Kettyle, et al.. (2017). High-Throughput Screen Identification of Albendazole As a Novel Repurposed Drug in Acute Myeloid Leukaemia. Blood. 130. 5062–5062. 3 indexed citations
9.
Hay, Jodie, Fabio G. Liberante, Laura M. Kettyle, et al.. (2017). Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy. Oncotarget. 8(40). 67891–67903. 5 indexed citations
10.
Kettyle, Laura M., et al.. (2017). Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy. Oncotarget. 8(31). 51429–51446. 31 indexed citations
11.
Kettyle, Laura M., Kyle B. Matchett, Joanne M. Ramsey, et al.. (2016). Low-dose salinomycin induces anti-leukemic responses in AML and MLL. Oncotarget. 7(45). 73448–73461. 14 indexed citations
12.
Matchett, Kyle B., Ivan Grishagin, Laura M. Kettyle, et al.. (2016). Mebendazole: A candidate FDA approved drug for repurposing in leukaemia. Research Portal (Queen's University Belfast). 2 indexed citations
13.
Kettyle, Laura M., et al.. (2016). Hoxa cluster genes determine the proliferative activity of adult mouse hematopoietic stem and progenitor cells. Blood. 127(1). 87–90. 24 indexed citations
14.
Kettyle, Laura M., Fabio G. Liberante, & Alexander Thompson. (2014). Rational Drug Repurposing Using sscMap Analysis in a HOX-TALE Model of Leukemia. Methods in molecular biology. 1196. 349–370. 1 indexed citations
15.
Kettyle, Laura M., et al.. (2013). c‐Met inhibition in a HOXA9/Meis1 model of CN‐AML. Developmental Dynamics. 243(1). 172–181. 10 indexed citations
16.
Dickson, Glenda J., Fabio G. Liberante, Laura M. Kettyle, et al.. (2013). HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy. Haematologica. 98(8). 1216–1225. 32 indexed citations
17.
Ramsey, Joanne M., Laura M. Kettyle, Daniel Sharpe, et al.. (2013). Entinostat Prevents Leukemia Maintenance in a Collaborating Oncogene-Dependent Model of Cytogenetically Normal Acute Myeloid Leukemia. Stem Cells. 31(7). 1434–1445. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026